Multicenter phase 2 study of nintedanib in patients (pts) with advanced progressing carcinoid tumors. Gemcitabine plus nab-paclitaxel until progression or given sequentially with 5-fluorouracile plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback